Cessatech A/S (NGM:CESSA)

Sweden flag Sweden · Delayed Price · Currency is SEK · Price in DKK
16.65
-0.40 (-2.35%)
At close: Apr 27, 2026
31.72%
Market Cap 447.31M
Revenue (ttm) 8.29M
Net Income (ttm) -15.80M
Shares Out 18.58M
EPS (ttm) -0.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,840
Average Volume 17,267
Open 16.90
Previous Close 17.05
Day's Range 16.65 - 18.00
52-Week Range 9.75 - 26.00
Beta 0.65
RSI 46.17
Earnings Date Feb 27, 2026

About Cessatech

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-clinical development. Cessatech A/S was incorporated in 2020 and is based in Copenhagen, Denmark. [Read more]

Industry Pharmaceutical Preparations
Founded 2020
Employees 3
Stock Exchange Nordic Growth Market
Ticker Symbol CESSA
Full Company Profile

Financial Performance

In 2025, Cessatech's revenue was 5.72 million, an increase of 130.01% compared to the previous year's 2.49 million. Losses were -10.90 million, -25.67% less than in 2024.

Financial numbers in DKK Financial Statements

News

There is no news available yet.